Home / Drug shortages / Decitabine Injection

Decitabine Injection — FDA Drug Shortage

To Be Discontinued — Ingenus Pharmaceuticals LLC

The FDA lists a drug shortage record for Decitabine Injection (injection) from Ingenus Pharmaceuticals LLC with status To Be Discontinued. The shortage was first posted on 02/20/2026.

Shortage Details

Status
To Be Discontinued
Company
Ingenus Pharmaceuticals LLC
Package NDC
68001-573-41
Dosage Form
Injection
Presentation
Decitabine, Injection, 50 mg (NDC 68001-573-41)
Initial Posting
02/20/2026
Revised Date

FDA data resources